NASDAQ Welcomes Lombard Medical Technologies, Inc. (NASDAQ: EVAR) to The NASDAQ Stock Market
GlobeNewswire - Fri Apr 25, 12:40PM CDT
The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) announced that trading of Lombard Medical, Inc. (Nasdaq:EVAR), the specialist medical device company focused on endovascular aortic repair of abdominal aortic aneurysms, commenced on The NASDAQ Stock Market on April 25, 2014.
Lombard Medical Technologies: Registration statement filed ahead of proposed IPO
Marketwire - Tue Mar 11, 2:11AM CDT
SOURCE: Lombard Medical Technologies PLC
Lombard Medical Technologies PLC: Pre-Close Trading and Strategic Update
Marketwire - Wed Jan 08, 1:10AM CST
SOURCE: Lombard Medical Technologies PLC
BioLife Solutions Appoints Raymond W. Cohen as Chairman and Joe Schick to Board of Directors
PR Newswire - Tue Nov 19, 5:00AM CST
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, today announced that it has appointed a new chairman of the board and also a new director.
Lombard Medical: Formal US Launch of Aorfix at VEITH Symposium
Marketwire - Mon Nov 18, 1:06AM CST
SOURCE: Lombard Medical Technologies PLC
Global Endovascular Abdominal Aortic Aneurysm Repair Devices Market 2012-2016: Leading Players Investing Heavily in R&D
M2 - Fri Sep 20, 6:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8v25k5/global) has announced the addition of the "Global Endovascular Abdominal Aortic Aneurysm Repair Devices Market 2012-2016" report to their offering. The analysts forecast the Global Endovascular Abdominal Aortic Aneurysm Repair Devices market to grow at a CAGR of 10.67 percent over the period 201-2016. One of the key factors contributing to this market growth is the high prevalence of abdominal aortic aneurysms. The Global Endovascular Abdominal Aortic Aneurysm Repair Devices market has also been witnessing the increasing demand for minimally invasive surgeries. However, the risk of complications and re-interventions associated with endovascular abdominal aortic aneurysm repair procedures could pose a challenge to the growth of this market. Commenting on the report, an analyst from the team said: One of the main trends witnessed in the Global Endovascular Abdominal Aortic Aneurysm Repair Devices market is the increasing number of mergers and acquisitions. Several leading vendors in the Global Endovascular AAA Repair Devices market have been focusing on mergers and acquisitions strategy to increase its global presence, mitigate of patent expiration losses, and achieve high economies of scale. For instance, Medtronic Inc. recently completed its acquisition of two privately held companies, PEAK Surgical Inc. and Salient Surgical Technologies Inc., to expand its innovative surgical product portfolio to meet the global customer and patient needs. According to the report, one of the main factors driving the market is prevalence of favorable reimbursement policies. To minimize the overall cost for patients, some countries have provided insurance schemes through which patients can be reimbursed for the cost of the treatment incurred. Further, the report states that one of the main challenges is the intense vendor competition. The global leading players are investing heavily in R&D to produce a broad range of advanced and high-end stents. Small and medium-sized vendors, however, are focused on marketing a single product line to a specific region in the globe, which is increasing the competition within the market. Companies Mentioned - Aptus Endosystems Inc. - Cardiatis S.A. - Cook Medical Inc. - Cordis Corp. - Endologix Inc. - JOTEC GmbH - LeMaitre Vascular Inc. - Lombard Medical Technologies PLC - Medtronic Inc. - Nano Endoluminal - Terumo Cardiovascular Systems Corp. - TriVascular Inc.. - W. L. Gore & Associates For more information visit http://www.researchandmarkets.com/research/8v25k5/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Lombard Medical Technologies PLC: First U.S. patients treated with Aorfix
Marketwire - Tue Aug 27, 2:03AM CDT
SOURCE: Lombard Medical Technologies PLC
Peripheral Vascular & Interventional Cardiology Devices Market Poised to Grow at a CAGR of 7.8% to Reach $12.7 Billion By 2016
M2 - Thu Jun 20, 10:58AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6kgwhn/peripheral) has announced the addition of the "Peripheral Vascular & Interventional Cardiology Devices Market (2011 - 2016) Global Trends & Competitive Analysis" report to their offering. The global vascular interventional devices market consist of devices used in both coronary and peripheral endovascular procedures which includes balloons, EVAR stent grafts, IVC filters, IVUS & angiography catheters, plaque modification devices, hemodynamic flow alteration devices and accessory devices. This Interventional Cardiology Devices Market was valued at $8.7 billion in 2011 and is poised to grow at a CAGR of 7.8% to reach $12.7 billion by 2016. Moreover, the global stents market for coronary and peripheral procedures was valued at $16.0 billion in 2011 and is expected to grow at a CAGR of 9.5% to reach $25.2 billion by 2016. A significant growth has been seen in the use of interventional endovascular procedures in the recent years, which is